Document is current
Any future updates will be listed below
-
Authors
Das, Krishna
Belnoue, Elodie
Rossi, Matteo
Hofer, Tamara
Danklmaier, Sarah
Nolden, Tobias
Schreiber, Liesa-Marie
Angerer, Katharina
Kimpel, Janine https://orcid.org/0000-0002-5210-7905
Hoegler, Sandra
Spiesschaert, Bart
Kenner, Lukas https://orcid.org/0000-0003-2184-1338
von Laer, Dorothee https://orcid.org/0000-0001-5825-7237
Elbers, Knut
Derouazi, Madiha https://orcid.org/0000-0002-5004-9705
Wollmann, Guido https://orcid.org/0000-0001-9894-842X
-
Funding
Funding for this research was provided by:
Österreichische Forschungsförderungsgesellschaft (877143)
Christian Doppler Forschungsgesellschaft
- License Information
-
More Information
Article History
Received: 9 December 2020
Accepted: 5 August 2021
First Online: 31 August 2021
Competing interests
: D.v.L. is inventor on a patent related to VSV-GP. D.v.L. and G.W. serve as scientific advisors for Boehringer Ingelheim GmbH. T.N., B.Sp. and K.E. are employees of ViraTherapeutics GmbH and Boehringer Ingelheim International GmbH. M.D. and E.B. are inventors on patents related to KISIMA vaccine platform. M.D., E.B., and M.R. are employees of AMAL Therapeutics and Boehringer Ingelheim International GmbH. The other authors declare no competing interest.
